0001211805 false --12-31 Q2 0001211805
2022-01-01 2022-06-30 0001211805 2022-08-08 0001211805 2022-06-30
0001211805 2021-12-31 0001211805 2021-01-01 2021-06-30 0001211805
2022-04-01 2022-06-30 0001211805 2021-04-01 2021-06-30 0001211805
us-gaap:CommonStockMember 2021-12-31 0001211805
us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31
0001211805 us-gaap:RetainedEarningsMember 2021-12-31 0001211805
us-gaap:CommonStockMember 2020-12-31 0001211805
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31
0001211805 us-gaap:RetainedEarningsMember 2020-12-31 0001211805
2020-12-31 0001211805 us-gaap:CommonStockMember 2022-03-31
0001211805 us-gaap:AdditionalPaidInCapitalMember 2022-03-31
0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31 0001211805 us-gaap:RetainedEarningsMember 2022-03-31
0001211805 2022-03-31 0001211805 us-gaap:CommonStockMember
2021-03-31 0001211805 us-gaap:AdditionalPaidInCapitalMember
2021-03-31 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31
0001211805 us-gaap:RetainedEarningsMember 2021-03-31 0001211805
2021-03-31 0001211805 us-gaap:CommonStockMember 2022-01-01
2022-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember
2022-01-01 2022-06-30 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01
2022-06-30 0001211805 us-gaap:RetainedEarningsMember 2022-01-01
2022-06-30 0001211805 us-gaap:CommonStockMember 2021-01-01
2021-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember
2021-01-01 2021-06-30 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01
2021-06-30 0001211805 us-gaap:RetainedEarningsMember 2021-01-01
2021-06-30 0001211805 us-gaap:CommonStockMember 2022-04-01
2022-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember
2022-04-01 2022-06-30 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01
2022-06-30 0001211805 us-gaap:RetainedEarningsMember 2022-04-01
2022-06-30 0001211805 us-gaap:CommonStockMember 2021-04-01
2021-06-30 0001211805 us-gaap:AdditionalPaidInCapitalMember
2021-04-01 2021-06-30 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01
2021-06-30 0001211805 us-gaap:RetainedEarningsMember 2021-04-01
2021-06-30 0001211805 us-gaap:CommonStockMember 2022-06-30
0001211805 us-gaap:AdditionalPaidInCapitalMember 2022-06-30
0001211805 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-06-30 0001211805 us-gaap:RetainedEarningsMember 2022-06-30
0001211805 us-gaap:CommonStockMember 2021-06-30 0001211805
us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001211805
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30
0001211805 us-gaap:RetainedEarningsMember 2021-06-30 0001211805
2021-06-30 0001211805 us-gaap:FairValueInputsLevel1Member
2022-06-30 0001211805 us-gaap:FairValueInputsLevel2Member
2022-06-30 0001211805 us-gaap:FairValueInputsLevel3Member
2022-06-30 0001211805 us-gaap:FairValueInputsLevel1Member
2021-12-31 0001211805 us-gaap:FairValueInputsLevel2Member
2021-12-31 0001211805 us-gaap:FairValueInputsLevel3Member
2021-12-31 0001211805 MYSZ:CostOfRevenuesMember 2022-01-01
2022-06-30 0001211805 MYSZ:CostOfRevenuesMember 2021-01-01
2021-06-30 0001211805 MYSZ:CostOfRevenuesMember 2022-04-01
2022-06-30 0001211805 MYSZ:CostOfRevenuesMember 2021-04-01
2021-06-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember
2022-01-01 2022-06-30 0001211805
us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30
0001211805 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01
2022-06-30 0001211805 us-gaap:ResearchAndDevelopmentExpenseMember
2021-04-01 2021-06-30 0001211805
us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-06-30
0001211805 us-gaap:SellingAndMarketingExpenseMember 2021-01-01
2021-06-30 0001211805 us-gaap:SellingAndMarketingExpenseMember
2022-04-01 2022-06-30 0001211805
us-gaap:SellingAndMarketingExpenseMember 2021-04-01 2021-06-30
0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01
2022-06-30 0001211805 us-gaap:GeneralAndAdministrativeExpenseMember
2021-01-01 2021-06-30 0001211805
us-gaap:GeneralAndAdministrativeExpenseMember 2022-04-01 2022-06-30
0001211805 us-gaap:GeneralAndAdministrativeExpenseMember 2021-04-01
2021-06-30 0001211805 MYSZ:ConsultantFourteenMember 2019-07-31
0001211805 MYSZ:ConsultantFourteenMember 2019-07-01 2019-07-31
0001211805 MYSZ:ConsultantFourteenMember MYSZ:AtExecutionMember
2019-07-31 0001211805 MYSZ:ConsultantFourteenMember
MYSZ:AtExecutionMember 2019-07-01 2019-07-31 0001211805
MYSZ:ConsultantFourteenMember 2022-01-01 2022-06-30 0001211805
MYSZ:ConsultantFourteenMember 2021-01-01 2021-06-30 0001211805
MYSZ:ConsultantFourteenMember 2022-04-01 2022-06-30 0001211805
MYSZ:ConsultantFourteenMember 2021-04-01 2021-06-30 0001211805
MYSZ:TwoThousandSeventeenEmployeePlanMember 2017-03-31 0001211805
MYSZ:EmployeesAndDirectorsMember 2020-05-25 0001211805
MYSZ:EmployeesAndDirectorsMember srt:MaximumMember 2020-05-25
0001211805 MYSZ:EmployeesAndDirectorsMember srt:MinimumMember
2020-05-25 0001211805 MYSZ:EmployeesAndDirectorsMember 2022-01-01
2022-06-30 0001211805 MYSZ:EmployeesAndDirectorsMember 2021-01-01
2021-06-30 0001211805 MYSZ:EmployeesAndDirectorsMember 2022-04-01
2022-06-30 0001211805 MYSZ:EmployeesAndDirectorsMember 2021-04-01
2021-06-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember
2020-08-09 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember
2020-08-10 0001211805
MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2020-08-09
0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember
2020-08-10 0001211805
MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember 2021-12-29
0001211805 MYSZ:TwoThousandSeventeenConsultantIncentivePlanMember
2021-12-30 0001211805 MYSZ:TwoThousandSeventeenEmployeePlanMember
2022-04-01 2022-06-30 0001211805 MYSZ:NorthEmpireLLCMember
MYSZ:SecuritiesPurchaseAgreementMember 2018-08-06 2018-08-07
0001211805 MYSZ:NorthEmpireLLCMember 2018-08-01 2018-08-02
0001211805 MYSZ:NorthEmpireLLCMember 2018-09-26 2018-09-27
0001211805 MYSZ:FidelityVentureCapitalLtdMember
MYSZ:MrDrorAtzmonMember 2021-07-04 2021-07-05 0001211805
MYSZ:FidelityVentureCapitalLtdMember MYSZ:MrDrorAtzmonMember
2021-07-05 0001211805 MYSZ:FidelityVentureCapitalLtdMember
MYSZ:MrDrorAtzmonMember 2022-04-10 2022-04-11 0001211805
MYSZ:OrgadMember 2022-02-07 0001211805 MYSZ:OrgadMember 2022-02-07
2022-06-30 0001211805 MYSZ:OrgadMember 2022-04-01 2022-06-30
0001211805 MYSZ:OrgadMember 2021-01-01 2021-12-31 0001211805
MYSZ:OrgadMember 2022-01-01 2022-06-30 0001211805 MYSZ:OrgadMember
MYSZ:EightEqualQuarterlyInstalmentsMember 2022-01-01 2022-06-30
0001211805 MYSZ:FashionAndEquipmentECommercePlatformMember
2022-01-01 2022-06-30 0001211805 MYSZ:SaasSolutionsMember
2022-01-01 2022-06-30 0001211805
MYSZ:FashionAndEquipmentECommercePlatformMember 2022-04-01
2022-06-30 0001211805 MYSZ:SaasSolutionsMember 2022-04-01
2022-06-30 0001211805
MYSZ:FashionAndEquipmentECommercePlatformMember 2022-06-30
0001211805 MYSZ:SaasSolutionsMember 2022-06-30 iso4217:USD
xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:ILS
U.
S. Securities and Exchange Commission
Washington,
D. C. 20549
FORM
10-Q
☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended
June 30,
2022
☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For
the transition period from _________ to _________
Commission
File No.
001-37370
MY SIZE, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
51-0394637 |
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
I.D.
No.)
|
HaYarden 4,
POB 1026,
Airport City,
Israel,
7010000
(Address
of principal executive offices)
+972-3-600-9030
Registrant’s
telephone number, including area code:
Securities registered pursuant to Section 12(b)
of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.001 par value per share |
|
MYSZ |
|
Nasdaq Capital Market |
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days.
Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated filer |
☒ |
Smaller
reporting company |
☒ |
|
|
Emerging
growth company |
☐ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act) Yes ☐
No ☒
Indicate
the number of shares outstanding of each of the issuer’s classes of
common stock, as of the latest practicable date: as of August 8,
2022,
25,551,906 shares of common stock, par value $0.001 per
share were issued and outstanding.
MY
SIZE, INC.
INDEX
TO QUARTERLY REPORT ON FORM 10-Q
FOR
THE QUARTER ENDED JUNE 30, 2022
TABLE
OF CONTENTS
PART
I
FINANCIAL
INFORMATION
Item
1. Financial Statements.
My
Size Inc. and Subsidiaries
Condensed
Consolidated
Interim
Financial
Statements
As
of June 30, 2022
(unaudited)
U.S.
Dollars in Thousands
MY
SIZE, INC. AND ITS SUBSIDIARIES
Condensed Consolidated Interim Financial Statements as of
June 30, 2022 (Unaudited)
Contents
MY
SIZE, INC. AND ITS SUBSIDIARIES
Condensed Consolidated Interim Balance Sheets
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
The
accompanying notes are an integral part of the condensed
consolidated interim financial statements.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Condensed Consolidated Interim Statements of Comprehensive
Loss (Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
The
accompanying notes are an integral part of the interim condensed
consolidated financial statements
MY
SIZE, INC. AND ITS SUBSIDIARIES
Condensed Consolidated Interim Statements of Changes in
Stockholders’ Equity (Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
|
|
Common stock |
|
|
Additional paid-in |
|
|
Accumulated other comprehensive |
|
|
Accumulated |
|
|
Total stockholders’ |
|
|
|
Number |
|
|
Amount |
|
|
capital |
|
|
loss |
|
|
deficit |
|
|
equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2021 |
|
|
7,232,836 |
|
|
|
7 |
|
|
|
37,164 |
|
|
|
(424 |
) |
|
|
(34,671 |
) |
|
|
2,076 |
|
Stock-based compensation related to
options granted to employees and consultants |
|
|
- |
|
|
|
- |
|
|
|
232 |
|
|
|
- |
|
|
|
- |
|
|
|
232 |
|
Restricted shares issued to
shareholder |
|
|
2,500,000 |
|
|
|
3 |
|
|
|
2,615 |
|
|
|
- |
|
|
|
- |
|
|
|
2,618 |
|
Issuance of shares, net of issuance cost of $768 |
|
|
4,580,491 |
|
|
|
4 |
|
|
|
5,031 |
|
|
|
- |
|
|
|
- |
|
|
|
5,035 |
|
Exercise of warrants |
|
|
725,000 |
|
|
|
1 |
|
|
|
796 |
|
|
|
- |
|
|
|
- |
|
|
|
797 |
|
Total
comprehensive loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(16 |
) |
|
|
(5,797 |
) |
|
|
(5,813 |
) |
Balance as of June 30, 2021 |
|
|
15,038,327 |
|
|
|
15 |
|
|
|
45,838 |
|
|
|
(440 |
) |
|
|
(40,468 |
) |
|
|
4,945 |
|
|
|
Common stock |
|
|
Additional paid-in |
|
|
Accumulated other comprehensive |
|
|
Accumulated |
|
|
Total stockholders’ |
|
|
|
Number |
|
|
Amount |
|
|
capital |
|
|
loss |
|
|
deficit |
|
|
equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of April 1, 2022 |
|
|
25,377,528 |
|
|
|
25 |
|
|
|
57,000 |
|
|
|
(348 |
) |
|
|
(47,379 |
) |
|
|
9,298 |
|
Stock-based compensation related to
options granted to employees and consultants |
|
|
- |
|
|
|
- |
|
|
|
48 |
|
|
|
- |
|
|
|
- |
|
|
|
48 |
|
Issuance of shares in Business
Combination (*) |
|
|
174,378 |
|
|
|
1 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1 |
|
Issuance of shares in Business Combination |
(*) |
|
174,378 |
|
|
|
1 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1 |
|
Total
comprehensive loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
64 |
|
|
|
(1,716 |
) |
|
|
(1,652 |
) |
Balance as of June 30, 2022 |
|
|
25,551,906 |
|
|
|
26 |
|
|
|
57,048 |
|
|
|
(284 |
) |
|
|
(49,095 |
) |
|
|
7,695 |
|
|
|
Common stock |
|
|
Additional paid-in |
|
|
Accumulated other comprehensive |
|
|
Accumulated |
|
|
Total stockholders’ |
|
|
|
Number |
|
|
Amount |
|
|
capital |
|
|
loss |
|
|
deficit |
|
|
equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of April 1, 2021 |
|
|
12,145,547 |
|
|
|
12 |
|
|
|
42,671 |
|
|
|
(462 |
) |
|
|
(36,128 |
) |
|
|
6,093 |
|
Stock-based compensation related to
options granted to employees and consultants |
|
|
- |
|
|
|
- |
|
|
|
89 |
|
|
|
- |
|
|
|
- |
|
|
|
89 |
|
Restricted shares issued to
shareholder |
|
|
2,500,000 |
|
|
|
3 |
|
|
|
2,615 |
|
|
|
- |
|
|
|
- |
|
|
|
2,618 |
|
Issuance of shares, net of issuance cost of $32 |
|
|
392,780 |
|
|
|
* |
|
|
|
463 |
|
|
|
- |
|
|
|
- |
|
|
|
463 |
|
Issuance of shares, net of issuance cost |
|
|
392,780 |
|
|
|
- |
(*) |
|
|
463 |
|
|
|
- |
|
|
|
- |
|
|
|
463 |
|
Total
comprehensive loss |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
22 |
|
|
|
(4,340 |
) |
|
|
(4,318 |
) |
Balance as of June 30, 2021 |
|
|
15,038,327 |
|
|
|
15 |
|
|
|
45,838 |
|
|
|
(440 |
) |
|
|
(40,468 |
) |
|
|
4,945 |
|
(*) |
Represents
an amount less than $1 |
The
accompanying notes are an integral part of the interim condensed
consolidated financial statements
MY
SIZE, INC. AND ITS SUBSIDIARIES
Condensed Consolidated Interim Statements of Cash Flows
(Unaudited)
U.S.
dollars in thousands
(*) |
$4,208
relates to change in cash and cash equivalents and $10 to change
in restricted cash. |
The
accompanying notes are an integral part of the interim condensed
consolidated financial statements.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
1 - General
|
a. |
My
Size, Inc. is developing unique measurement technologies based on
algorithms with applications in a variety of areas, from the
apparel e-commerce market to the courier services market and to the
Do It Yourself smartphone and tablet apps market. The technology is
driven by proprietary algorithms which are able to calculate and
record measurements in a variety of novel ways.
Following
the acquisition of Orgad International Marketing Ltd. (“Orgad”) in
February 2022 (see note 6), the Company also operates an
omnichannel e-commerce platform.
The
Company has four subsidiaries, My Size Israel 2014 Ltd (“My Size
Israel”), Topspin Medical (Israel) Ltd., and Orgad all of which are
incorporated in Israel, and My Size LLC which was incorporated in
the Russian Federation. References to the Company include the
subsidiaries unless the context indicates otherwise.
|
|
|
|
|
b. |
During
the six-month period ended June 30, 2022, the Company has incurred
significant losses and negative cash flows from operations and has
an accumulated deficit of $49,095. The
Company has financed its operations mainly through fundraising from
various investors.
The
Company’s management expects that the Company will continue to
generate losses and negative cash flows from operations for the
foreseeable future. Based on the projected cash flows and cash
balances as of June 30, 2022, management is of the opinion that its
existing cash will be sufficient to fund operations for a period
less than 12 months. As a result, there is substantial doubt about
the Company’s ability to continue as a going concern.
Management’s
plans include the continued commercialization of the Company’s
products and securing sufficient financing through the sale of
additional equity securities, debt or capital inflows from
strategic partnerships. Additional funds may not be available when
the Company needs them, on terms that are acceptable to it, or at
all. If the Company is unsuccessful in commercializing its products
and securing sufficient financing, it may need to cease
operations.
The
financial statements include no adjustments for measurement or
presentation of assets and liabilities, which may be required
should the Company fail to operate as a going concern.
|
|
|
|
|
c. |
In
late 2019, a novel strain of COVID-19, also known as coronavirus,
was reported in Wuhan, China. While initially the outbreak was
largely concentrated in China, it spread globally. Many countries
around the world, including Israel, have from time to time
implemented significant governmental measures to control the spread
of the virus, including temporary closure of businesses, severe
restrictions on travel and the movement of people, and other
material limitations on the conduct of business. While the COVID-19
pandemic did not materially adversely affect the Company’s
consolidated financial results and operations during the three and
six months ended June 30, 2022, the COVID-19 pandemic affected the
Company’s operations in 2020 and 2021. The pandemic may continue to
have an impact on the Company’s business, operations, and financial
results and conditions, directly and indirectly, including, without
limitation, impacts on the health of the Company’s management and
employees, its operations, marketing and sales activities, and on
the overall economy. The extent to which COVID-19 impacts the
Company’s operations will depend on future developments, which are
highly uncertain and cannot be predicted with confidence, including
the duration and severity of the outbreak, and the actions that may
be required to contain COVID-19 or treat its impact.
|
Note
2 - Significant
Accounting Policies
|
a. |
Unaudited
condensed consolidated financial statements: |
|
|
|
|
|
The
accompanying unaudited condensed consolidated interim financial
statements included herein have been prepared by the Company in
accordance with the rules and regulations of the United States
Securities and Exchange Commission (“SEC”). The unaudited condensed
consolidated financial statements are comprised of the financial
statements of the Company. In management’s opinion, the interim
financial data presented includes all adjustments necessary for a
fair presentation. All intercompany accounts and transactions have
been eliminated. Certain information required by U.S. generally
accepted accounting principles (“GAAP”) has been condensed or
omitted in accordance with rules and regulations of the SEC.
Operating results for the six months ended June 30, 2022 are not
necessarily indicative of the results that may be expected for any
future period or for the year ending December 31, 2021. |
|
|
|
|
|
These
unaudited condensed consolidated financial statements should be
read in conjunction with the Company’s audited consolidated
financial statements and the notes thereto for the year ended
December 31, 2021.
|
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
2 - Significant Accounting Policies (cont.)
|
b. |
Significant
Accounting Policies: |
|
|
|
|
|
The
significant accounting policies followed in the preparation of
these unaudited interim condensed consolidated financial statements
are identical to those applied in the preparation of the latest
annual financial statements, except the following new policies
which was adopted following the business combination (see note
6): |
Inventories
are measured at the lower of cost or net realizable value. The cost
of inventories comprises of the costs incurred in bringing the
inventories to their present location and condition. Net realizable
value is the estimated selling price in the ordinary course of
business. At the point of the loss recognition, a new, lower-cost
basis for that inventory is established, and subsequent changes in
facts and circumstances do not result in the restoration or
increase in that newly established cost basis.
Since
the acquisition of Orgad (see note 6 - Business combination), the
Company’s revenues are comprised of two main categories: (1)
selling products to customers (2) licensing cloud-enabled software
subscriptions, associated software maintenance and
support.
Revenue from sale of products
Revenue
from sale of products is recognized at the time the related
performance obligation is satisfied by transferring a promised good
to a customer. Revenue is recognized net of allowances for refunds
and any taxes collected from customers, which are subsequently
remitted to governmental authorities. Refunds are estimated at
contract inception and updated at the end of each reporting period
if additional information becomes available. Revenue is recognized
when control of the product is transferred to the
customer.
The
Company maintains a returns policy that allows its customers to
return product within a specified period of time. The estimate of
the provision for returns is based upon historical experience with
actual returns.
Revenue from licensing
The
Company recognizes revenue in accordance with ASC Topic 606,
Revenues from Contracts with Customers (“ASC 606”). A contract with
a customer exists only when: the parties to the contract have
approved it and are committed to perform their respective
obligations, the Company can identify each party’s rights regarding
the distinct goods or services to be transferred (“performance
obligations”), the Company can determine the transaction price for
the goods or services to be transferred, the contract has
commercial substance and it is probable that the Company will
collect the consideration to which it will be entitled in exchange
for the goods or services that will be transferred to the
customer.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
2 - Significant Accounting Policies (cont.)
Principal versus Agent Considerations
The
Company follows the guidance provided in ASC 606 for determining
whether it is a principal or an agent in arrangements with
customers, by assessing whether the nature of the Company’s promise
is a performance obligation to provide the specified goods
(principal) or to arrange for those goods to be provided by the
other party (agent). With regard to products being sold by Orgad
through Amazon, this determination involves judgment. The Company
determined it is a principal, as it has determined that it controls
the promised product before it is transferred to the end customers,
it is primarily responsible for fulfilling the promise to provide
the goods, and it has discretion in establishing prices. Therefore,
the revenues are recorded on a gross basis.
The Company applies the provisions of ASC 805, “Business
Combination” and allocates the fair value of purchase consideration
to the tangible assets acquired, liabilities assumed, and
intangible assets acquired based on their estimated fair values.
The excess of the fair value of purchase consideration over the
fair values of these identifiable assets and liabilities is
recorded as goodwill. When determining the fair values of assets
acquired and liabilities assumed, the Company estimated the future
expected cash flows from acquired platform from a market
participant perspective, useful lives and discount rates. In
addition, management makes significant estimates and assumptions,
which are uncertain, but believed to be reasonable.
Significant estimates in valuing certain intangible assets include
but are not limited to future expected cash flows from acquired
platforms from a market participant perspective, useful lives and
discount rates. Management’s estimates of fair value are based upon
assumptions believed to be reasonable, but which are inherently
uncertain and unpredictable and, as a result, actual results may
differ from estimates.
Acquisition-related costs are recognized separately from the
acquisition and are expensed as incurred.
Goodwill
represents the excess of the purchase price over the fair value of
the net tangible and intangible assets acquired in a business
combination. Under ASC 350, “Intangible - Goodwill and Other”,
goodwill is not amortized, but rather is subject to an annual
impairment test.
ASC
350 requires goodwill to be tested for impairment at the reporting
unit level at least annually, the fourth quarter, or between annual tests
in certain circumstances, and written down when impaired. Goodwill
is tested for impairment by comparing the fair value of the
reporting unit with it carrying value.
ASC
350 allows an entity
to first assess qualitative factors to determine whether it is
necessary to perform the two-step quantitative goodwill impairment
test. If the qualitative assessment does not result in a more
likely than not indication of impairment, no further impairment
testing is required. If it does result in a more likely than not
indication of impairment, the two-step impairment test is
performed. Goodwill is not deductible for income tax purposes.
Goodwill is allocated to the fashion and equipment e-commerce
platform segment.
Alternatively, ASC
350 permits an entity to bypass the qualitative assessment for any
reporting unit and proceed directly to performing the first step of
the goodwill impairment test. There were no impairment charges to
goodwill during the period presented.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
2 - Significant Accounting Policies (cont.)
Intangible
assets consist of identifiable intangible assets that the Company
has acquired from previous business combinations. Intangible assets
are recorded at costs, net of accumulated amortization. The Company
amortizes its intangible assets reflecting the pattern in which the
economic benefits of the intangible assets are consumed. When a
pattern cannot be reliably determined, the Company uses a
straight-line amortization method.
The
estimated useful lives of the company’s intangible assets are as
follows:
Schedule of Intangible Assets Estimated
Useful Lives
Each
period the Company evaluates the estimated remaining useful lives
of its intangible assets and whether events or changes in
circumstances warrant a revision to the remaining period of
amortization
The
preparation of consolidated financial statements in conformity with
GAAP requires us to make estimates and assumptions that affect the
amounts reported and disclosed in the financial statements and the
accompanying notes. Actual results could differ materially from
these estimates.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
3 - Financial
Instruments
The
carrying amounts of cash and cash equivalents, accounts receivable,
other receivables, trade payables and accounts payable approximate
their fair value due to the short-term maturities of such
instruments. In addition, the carrying amounts of a long term loan
is approximate to its fair value because there was no change in the
market conditions since its exceptions.
The
Company holds share certificates in iMine Corporation (“iMine”)
formerly known as Diamante Minerals, Inc., a publicly traded
company on the OTCQB.
Due
to sales restrictions on the sale of the iMine shares, the fair
value of the shares was measured on the basis of the quoted market
price for an otherwise identical unrestricted equity instrument of
the same issuer that trades in a public market, adjusted to reflect
the effect of the sales restrictions and is therefore, ranked as
Level 2 assets.
Schedule of Significant Assets and Liabilities
Measured at Fair Value on Recurring Basis
|
|
June 30, 2022 |
|
|
|
Fair value hierarchy |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in marketable securities (*) |
|
|
- |
|
|
|
97 |
|
|
|
- |
|
|
|
June 30, 2022 |
|
|
|
Fair value hierarchy |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial
liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
|
- |
|
|
|
39 |
|
|
|
- |
|
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
3 - Financial Instruments (Cont.)
|
|
December 31, 2021 |
|
|
|
Fair value hierarchy |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment in marketable securities (*) |
|
|
- |
|
|
|
108 |
|
|
|
- |
|
(*) |
For
the six and three-month periods ended June 30, 2022 and 2021, the
recognized gain (loss) (based on quoted market prices with a
discount due to security restrictions on iMine shares) of the
marketable securities was ($11)
and $3,
and $(22)
and $(27)
respectively. |
|
|
December 31, 2021 |
|
|
|
Fair value hierarchy |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
Financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
|
- |
|
|
|
2 |
|
|
|
- |
|
Note
4 - Stock Based
Compensation
The
stock-based expense equity awards recognized in the financial
statements for services received is related to Cost of Revenues,
Research and Development, Sales and Marketing and General and
Administrative expenses as shown in the following table:
Schedule of Stock Based Compensation Expenses
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
Six months ended
June 30,
|
|
|
Three months ended
June 30,
|
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense –
Cost of revenues |
|
|
28
|
|
|
|
-
|
|
|
|
7
|
|
|
|
-
|
|
Stock-based compensation
expense - Research and development |
|
|
18 |
|
|
|
70 |
|
|
|
6
|
|
|
|
9 |
|
Stock-based compensation expense -
Sales and marketing |
|
|
58 |
|
|
|
93 |
|
|
|
19 |
|
|
|
68 |
|
Stock-based
compensation expense - General and administrative |
|
|
58 |
|
|
|
69 |
|
|
|
16 |
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
162
|
|
|
|
232 |
|
|
|
48
|
|
|
|
89 |
|
Options
issued to consultants:
|
|
In
July 2019, the Company entered into a three-year agreement with a
consultant (“Consultant14”) to provide services to the Company
including assisting the Company to promote, market and sell the
Company’s technology to potential customers. Pursuant to such
agreement and in partial consideration for such consulting
services, the Company agreed to issue to Consultant14 options to
purchase up to
2,667 shares of the Company’s common stock upon execution of
the agreement. The options are exercisable at $15.00
per share and shall vest in 3 equal instalments every twelve months
starting July 2019. Unexercised options shall expire
4 years from the effective date. |
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
4 - Stock Based Compensation (Cont.)
|
|
In
addition, the Company agreed to issue to Consultant14 options to
purchase up to 22,233
shares of the Company’s common stock upon execution of the
agreement. The options are exercisable at $1.08
per share and shall vest in 4 equal instalments every six months
starting September 2020. Unexercised options shall expire
5 years from the effective date. |
During
the six and three-month period ended June 30,2022 and 2021, an
amount of $7 and $4, and $7
and $4
respectively, were recorded by the Company as stock-based equity
awards with respect to Consultants.
Stock
Option Plan for Employees:
In
March 2017, the Company adopted the My Size, Inc. 2017 Equity
Incentive Plan (the “2017 Employee Plan”) pursuant to which the
Company’s Board of Directors may grant stock options to officers
and key employees. The total number of options which may be granted
to directors, officers, employees under this plan, is limited to
5,770,000
options. Stock options can be granted with an exercise price equal
to or less than the stock’s fair market value at the date of
grant.
On
May 25, 2020, the compensation committee of the Board of Directors
of the Company reduced the exercise price of outstanding options of
employees and directors of the Company for the purchase of an
aggregate of 140,237
shares of common stock of the Company (with exercise prices ranging
between $18.15
and $9.15)
to $1.04
per share, which was the closing price for the Company’s common
stock on May 22, 2020, and extended the term of the foregoing
options for an additional one year from the original date of
expiration. The incremental compensation cost resulting from the
repricing was $53, and the expenses during the
six-month period ended June 30, 2022 and 2021 were $2 and $1, respectively
and the expenses during the three months ended June 30, 2022 and
2021 were $47 and $53,
respectively.
On
August 10, 2020, the Company’s shareholders approved an increase in
the shares available for issuance under the 2017 Employee Plan from
200,000 to
1,450,000
shares. As a result, and pursuant to approval of the Company’s
compensation committee that was contingent on the foregoing
shareholder approval, the number of shares available for issuance
under the Company’s 2017 Consultant Incentive Plan was reduced from
466,667 to
216,667 shares.
On December 30, 2021, the Company’s shareholders approved an
increase in the shares available for issuance under the 2017 Equity
Incentive Plan from 1,450,000
shares to 5,770,000
shares.
During
the six and three-month period ended June 30, 2022, the Company did
not grant any stock options under the 2017 Employee Plan, no
options were exercised and options to purchase 51,873
shares
of common stock, expired.
The
total stock option compensation expense during the six and
three-month period ended June 30, 2022 and 2021 which was recorded
was $44 and
$171, and
$15 and
$103,
respectively.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
5 - Contingencies and
Commitments
|
a. |
On
August 7, 2018, the Company commenced an action against North
Empire LLC (“North Empire”) in the Supreme Court of the State of
New York, County of New York for breach of a Securities Purchase
Agreement (the “Agreement”) in which it is seeking damages in an
amount to be determined at trial, but in no event less than
$616
thousands. On August 2, 2018, North Empire filed a Summons
with Notice against the Company, also in the same Court, in which
they allege damages in an amount of $11.4 million
arising from an alleged breach of the Agreement. On September 6,
2018 North Empire filed a Notice of Discontinuance of the action it
had filed on August 2, 2018. On September 27, 2018, North Empire
filed an answer and asserted counterclaims in the action commenced
by the Company against them, alleging that the Company failed to
deliver stock certificates to North Empire causing damage to North
Empire in the amount of $10,958,589.
North Empire also filed a third-party complaint against the
Company’s CEO and now former Chairman of the Board asserting
similar claims against them in their individual capacities. On
October 17, 2018, the Company filed a reply to North Empire’s
counterclaims. On November 15, 2018, the Company’s CEO and now
former Chairman of the Board filed a motion to dismiss North
Empire’s third-party complaint. On January 6, 2020, the Court
granted the motion and dismissed the third-party complaint.
Discovery has been completed and both parties have filed motions
for summary judgment in connection with the claims and
counterclaims. On December 30, 2021, the Court denied both My Size
and North Empire’s motions for summary judgment, arguing there were
factual issues to be determined at trial. On January 26, 2022, the
Company filed a notice of appeal of the summary judgment decision.
The appeal must be fully perfected and filed by September 24, 2022.
On February 3, 2022, the Company filed a motion to reargue the
Court’s decision denying the Company’s motion for summary judgment.
On or about March 31, 2022, North Empire filed its opposition
papers to the Company’s motion to reargue. On or about May 20, 2022
the Company filed its reply papers, in further support of its
motion to reargue. That motion is now fully briefed and the Company
is waiting on a decision from the Court.
The
Company believes it is more likely than not that the counterclaims
will be denied.
|
|
|
|
|
b. |
On
July 5, 2021, the Company was served with a legal complaint filed
by Fidelity Venture Capital Ltd. and Dror Atzmon in the
Magistrate’s Court in Tel Aviv for a monetary award in an amount of
NIS 1,436,679
(approximately $450) and a
declaratory relief. The plaintiffs allege that the Company breached
its contractual obligations to pay them for services allegedly
rendered to the Company by the plaintiffs under a certain
consulting agreement dated July 2, 2014, in an amount of NIS
819,000
(approximately $256).
Additionally, the plaintiffs allege that the Company should
compensate them for losses allegedly incurred by them following
their investment in the Company’s shares issued under a certain
private offering. In the alternative, the plaintiffs move that the
court will declare the investment agreement void with full
restitution of plaintiffs’ original investment in an amount of NIS
1,329,650
(approximately $415). The
Company filed its statement of defense on October 25, 2021. The
first court preliminary hearing was held on March 1, 2022.
Following the first preliminary hearing and the Court’s comments
and recommendation, the plaintiffs filed a motion to strike out the
claim without prejudice. On March 8, 2022 the Court ordered
dismissal without prejudice of the claim. The Court also ruled that
to the extent the plaintiffs will not move within 7 days to revise
their motion do dismiss their claim “with prejudice”, the Company
will be entitled to request an order for costs. On April 11, 2022
the Court ordered the plaintiffs to pay the Company’s costs in the
amount of NIS 15,000, within
30 days. |
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
6 – Business
Combination
Acquisition of Orgad
On February 7, 2022, the Company acquired
100%
of the shares and voting interests in Orgad an omnichannel e-commerce platform.
The acquisition was designed to create an additional revenue stream
for the Company by becoming a direct e-commerce seller while
leveraging the synergies between MySizeID and Orgad’s e-commerce
platform.
The results of operations of Orgad have been included in the
consolidated financial statements since the acquisition date of
February 7, 2022. Orgad revenues included in the Company’s
consolidated statement of operations from February 7, 2022 through
June 30, 2022 were $1,112 and
for the three-month period ended June 30, 2022 were $752.
If
the acquisition had occurred on January 1, 2021, management
estimates that the consolidated pro forma revenues for the year
would have been $2,768, and the net loss would have
been $2,272.
|
(a) |
Consideration transferred |
The
following table summarizes the acquisition date fair value of each
major class of consideration:
Schedule of Fair value of the
Acquisition
|
|
USD |
|
|
|
Thousands
|
|
Cash (*) |
(*) |
|
300 |
|
Issuance of shares of common
stock (1,395,025 shares)
(**) |
(**) |
|
457 |
|
Total
consideration transferred |
|
|
757 |
|
(*) |
The
cash payment is subject to working capital adjustments. |
|
|
(**) |
Quoted
price as of acquisition date |
In
addition, the Company agreed to pay to the former owners of Orgad,
on the two-year and the three-year anniversary of the closing,
$350,000 in
each of these years provided that in the case of the second and
third instalments certain revenue targets are met and subject
further to certain downward post-closing adjustment. Furthermore,
1,395,024
shares of common stock will be issued in eight equal quarterly
instalments until the lapse of two years from closing. Additional
earn-out payments of 10% of the operating profit of
Orgad for the years 2022 and 2023 will also be paid. All of these
payments are subject to the former owners being actively engaged
with Orgad at the date such payment is due, and therefore were not
taken as part of the consideration for the business
combination.
During the six and three-month period ended June 30, 2022 an amount
of $111 and $28 was recorded in respect of the
cash instalments respectively, and $127 and $54 in respect of stocks issuance,
respectively.
|
(b) |
Identifiable assets acquired and liabilities
assumed |
Under the preliminary purchase price allocation, the Company
allocated the purchase price to tangible and identified intangible
assets acquired and liabilities assumed based on the preliminary
estimates of their fair values, which were determined using
generally accepted valuation techniques based on estimates and
assumptions made by management at the time of the acquisition. Such
estimates are subject to change during the measurement period which
is not expected to exceed one year. The purchase price allocation
was not finalized duo to examination of the net working capital of
Orgad at the acquisition date. Any adjustments to the preliminary
purchase price allocation identified during the measurement period
will be recognized in the period in which the adjustments are
determined.
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
6 – Business Combination (Cont.)
The following table summarizes the preliminary fair value of assets
acquired and liabilities assumed as of the acquisition
date:
Schedule of Fair Value of Assets Acquired and
Liabilities
|
|
Thousands
USD |
|
Cash and Cash
Equivalent |
|
|
0 |
|
Trade receivables |
|
|
89 |
|
Other receivables |
|
|
239 |
|
Inventory |
|
|
864 |
|
Fixed assets |
|
|
55 |
|
Long-term deposits |
|
|
31 |
|
Selling platform (*) |
|
|
378 |
|
Goodwill |
|
|
268 |
|
Short-term credit |
|
|
(181 |
) |
Trade payables |
|
|
(660 |
) |
Other payables |
|
|
(101 |
) |
Long-term loan |
|
|
(138 |
) |
Deferred
Taxes |
|
|
(87 |
) |
Total net
assets acquired |
|
|
757 |
|
|
(*) |
The
estimated useful lives of the selling platform are
three years. During the six and three-month period ended
June 30,2022 an amount of $52
and
$32
was recorded in respect of amortization expenses. |
|
(c) |
Acquisition-related costs |
The
Company incurred transaction costs of approximately $55 and none during
the six-month and three-month period ended June 31, 2022
which were included in
general and administrative expenses in the consolidated statements
of income (loss), (the total amount recorded during the first
quarter of the year).
MY
SIZE, INC. AND ITS SUBSIDIARIES
Notes
to Condensed Consolidated Interim Financial Statements
(Unaudited)
U.S.
dollars in thousands (except share data and per share
data)
Note
7 – Operating
Segments
As a result of the business combination in the reporting period
(see note 6), the company has two reportable segments: (i) fashion
and equipment e-commerce platform and (ii) SaaS based innovative
artificial intelligence driven measurement solutions. The fashion
and equipment e-commerce platform which represent Orgad’s activity
that was acquired by the Company, mainly operates on Amazon. The
SaaS based innovative artificial intelligence driven measurement
solutions, or SaaS Solutions operating segment consists of My Size
Inc and My Size Israel.
Information
related to the operations of the Company’s reportable operating
segments is set forth below:
Schedule of Reportable Operating
Segments
|
|
Fashion and
equipment e-commerce platform |
|
|
SaaS
Solutions
|
|
|
Total |
|
For the six months ended June
30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
1,112 |
|
|
|
93 |
|
|
|
1,205 |
|
Operating (loss) income |
|
|
71 |
|
|
|
(3,828 |
) |
|
|
(3,757 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended June
30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
752 |
|
|
|
49 |
|
|
|
801 |
|
Operating (loss) income |
|
|
(2 |
) |
|
|
(1,650 |
) |
|
|
(1,652 |
) |
|
|
Fashion
and equipment e-commerce platform |
|
|
SaaS
Solutions
|
|
For June 30, 2022: |
|
|
|
|
|
|
|
|
Assets |
|
|
1,860 |
|
|
|
8,806 |
|
Note
8 – Subsequent
events
In
July 2022, Amazon deactivated Orgad’s Amazon U.S. store as a result
of complaints submitted due to an error in the listed manufacturer
of certain products on Orgad’s store. Orgad resolved the complaints
and is presently in the process of having its account
reinstated.
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.
The
following discussion and analysis provide information that we
believe to be relevant to an assessment and understanding of our
results of operations and financial condition for the periods
described. This discussion should be read together with our
condensed consolidated interim financial statements and the notes
to the financial statements, which are included in this Quarterly
Report on Form 10-Q. This information should also be read in
conjunction with the information contained in our Annual Report on
Form 10-K for the year ended December 31, 2021, filed with the
Securities and Exchange Commission on March 31, 2022, or the Annual
Report, including the consolidated annual financial statements as
of December 31, 2021, and their accompanying notes included
therein.
This
Quarterly Report on Form 10-Q contains certain forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, or the Securities Act, and Section 21E of the
Securities Exchange Act of 1934, as amended. Any statements in this
Quarterly Report on Form 10-Q about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are
not historical facts and are forward-looking statements. These
statements are often, but not always, made through the use of words
or phrases such as “believe,” “will,” “expect,” “anticipate,”
“estimate,” “intend,” “plan” and “would.” For example, statements
concerning financial condition, possible or assumed future results
of operations, growth opportunities, industry ranking, plans and
objectives of management, markets for our common stock and future
management and organizational structure are all forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results, levels of activity,
performance or achievements to differ materially from any results,
levels of activity, performance or achievements expressed or
implied by any forward-looking statement.
Any
forward-looking statements are qualified in their entirety by
reference to the risk factors discussed throughout this Quarterly
Report on Form 10-Q. Some of the risks, uncertainties and
assumptions that could cause actual results to differ materially
from estimates or projections contained in the forward-looking
statements include but are not limited to:
|
● |
our
history of losses and needs for additional capital to fund our
operations and our inability to obtain additional capital on
acceptable terms, or at all; |
|
|
|
|
● |
our
ability to continue as a going concern; |
|
|
|
|
● |
risks
related to the COVID-19 pandemic; |
|
|
|
|
● |
the
new and unproven nature of the measurement technology
markets; |
|
|
|
|
● |
our
ability to achieve customer adoption of our
products; |
|
|
|
|
● |
our
dependence on assets we purchased from a related party and the risk
that such assets may in the future be repurchased; |
|
|
|
|
● |
our
ability to enhance our brand and increase market
awareness; |
|
|
|
|
● |
our
ability to introduce new products and continually enhance our
product offerings; |
|
|
|
|
● |
the
success of our strategic relationships with third
parties; |
|
|
|
|
● |
information
technology system failures or breaches of our network
security; |
|
|
|
|
● |
competition
from competitors; |
|
|
|
|
● |
our
reliance on key members of our management team; |
|
|
|
|
● |
current
or future litigation; and |
|
|
|
|
● |
the
impact of the political and security situation in Israel on our
business. |
The
foregoing list sets forth some, but not all, of the factors that
could affect our ability to achieve results described in any
forward-looking statements. You should read this Quarterly Report
on Form 10-Q and the documents that we reference herein and have
filed as exhibits to the Quarterly Report on Form 10-Q completely
and with the understanding that our actual future results may be
materially different from what we expect. You should assume that
the information appearing in this Quarterly Report on Form 10-Q is
accurate as of the date hereof. Because the risk factors referred
to on page 12 of our Annual Report, could cause actual results or
outcomes to differ materially from those expressed in any
forward-looking statements made by us or on our behalf, you should
not place undue reliance on any forward-looking statements.
Further, any forward-looking statement speaks only as of the date
on which it is made, and we undertake no obligation to update any
forward-looking statement to reflect events or circumstances after
the date on which the statement is made or to reflect the
occurrence of unanticipated events. New factors emerge from time to
time, and it is not possible for us to predict which factors will
arise. In addition, we cannot assess the impact of each factor on
our business or the extent to which any factor, or combination of
factors, may cause actual results to differ materially from those
contained in any forward-looking statements.
Unless
the context otherwise requires, all references to “we,” “us,” “our”
or “the Company” in this Quarterly Report on Form 10-Q are to My
Size, Inc. a Delaware corporation, and its subsidiaries, including
MySize Israel 2014 Ltd, Topspin Medical (Israel) Ltd, Orgad
International Marketing Ltd., or Orgad and My Size LLC. taken as a
whole.
Overview
We
are a creator of mobile device measurement solutions that has
developed innovative solutions designed to address shortcomings in
multiple verticals, including the e-commerce fashion/apparel,
shipping/parcel and do it yourself, or DIY, industries. Utilizing
our sophisticated algorithms within our proprietary technology, we
can calculate and record measurements in a variety of novel ways,
and most importantly, increase revenue for businesses across the
globe.
Our
solutions can be utilized to accurately take measurements of a
variety of items via a mobile device. By downloading the
application to a smartphone, the user is then able to run the
mobile device over the surface of an item the user wishes to
measure. The information is then automatically sent to a
cloud-based server where the dimensions are calculated through our
proprietary algorithms, and the accurate measurements (+ or - 2
centimeters) are then sent back to the user’s mobile device. We
believe that the commercial applications for this technology are
significant in many areas.
Currently,
we are mainly focusing on the e-commerce fashion/apparel industry.
In addition, our solutions address the shipping/parcel and DIY uses
markets.
While
we rollout our products to major retailers and apparel companies,
there is a lead time for new customers to ramp up before we can
recognize revenue. This lead time varies between customers,
especially when the customer is a tier 1 retailer, where the
integration process may take longer. Generally, first we integrate
our product into a customer’s online platform, which is followed by
piloting and implementation, and, assuming we are successful,
commercial roll-out, all of which takes time before we expect it to
impact our financial results in a meaningful way. While we have
begun generating initial sales revenue, we do not expect to
generate meaningful revenue during the upcoming quarters. Because
of the numerous risks and uncertainties associated with the success
of our market penetration and our dependence on the extent to which
MySizeID is adopted and utilized, we are unable to predict the
extent to which we will recognize revenue. We may be unable to
successfully develop or market any of our current or proposed
products or technologies, those products or technologies may not
generate any revenues, and any revenues generated may not be
sufficient for us to become profitable or thereafter maintain
profitability.
Orgad
Acquisition
On
February 7, 2022, My Size Israel 2014 Ltd, or My Size Israel,
entered into a Share Purchase Agreement, or the Orgad Agreement,
with Amar Guy Shalom and Elad Bretfeld, or the Orgad Sellers,
pursuant to which the Orgad Sellers agreed to sell to My Size
Israel all of the issued and outstanding equity of
Orgad.
Orgad
operates an omnichannel e-commerce platform engaged in online
retailing in the global market. It operates as a third-party seller
on Amazon.com, eBay and others. Orgad currently manages more than
1,000 stock-keeping units, or SKUs, mainly in fashion, apparel and
shoes, but is capable of managing tens of thousands of
SKUs.
The
Orgad Sellers are the sole title and beneficial owners of 100% of
the shares of Orgad. In consideration of the shares of Orgad, the
Orgad Sellers are entitled to receive (i) up to $1,000,000 in cash,
or the Orgad Cash Consideration, (ii) an aggregate of 2,790,049
shares, or the Orgad Equity Consideration, of our common stock, and
(iii) earn-out payments of 10% of the operating profit of Orgad for
the years 2022 and 2023. The transaction closed on the same
day.
The
Orgad Cash Consideration is payable to the Orgad Sellers in three
installments, according to the following payment schedule: (i)
$300,000 which we paid upon closing, (ii) $350,000 payable on the
two-year anniversary of the closing, and (iii) $350,000 payable on
the three-year anniversary of the closing, provided that in the
case of the second and third installments certain revenue targets
are met and subject further to certain downward post-closing
adjustment.
The
Equity Consideration is payable to the Orgad Sellers according to
the following payment schedule: (i) 1,395,025 shares were issued at
closing, and (ii) 1,395,024 shares will be issued in eight equal
quarterly installments until the lapse of two years from closing,
subject to certain downward post-closing adjustment.
The
payment of the second and third cash installments, the equity
installments and the earn out are further subject in each case to
the Orgad Sellers being actively engaged with Orgad at the date
such payment is due (except if the Orgad Sellers resign due to
reasons relating to material reduction of salary or adverse change
in their position with Orgad or its affiliates).
In
connection with the Orgad Agreement, each of the Orgad Sellers
entered into employment agreements with Orgad and six-month lock-up
agreements with us.
Operations in Russia
In
addition to our Israel operations, we have operations in Russia
through our wholly owned subsidiary, My Size LLC. Specifically, we
undertake some of our sales and marketing using personnel located
in Russia. To date, the invasion of Ukraine by Russia has not had a
material impact on our business.
Results
of Operations
The
table below provides our results of operations for the periods
indicated.
|
|
Three months
ended
June 30
|
|
|
Six months ended
June 30
|
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
(dollars in thousands) |
|
|
(dollars in thousands) |
|
Revenues |
|
$ |
801
|
|
|
$ |
30 |
|
|
$ |
1,205
|
|
|
$ |
57 |
|
Cost of revenues |
|
|
(479 |
) |
|
|
- |
|
|
|
(730
|
) |
|
|
- |
|
Gross profit |
|
|
322 |
|
|
|
30 |
|
|
|
475
|
|
|
|
57 |
|
Research and development expenses |
|
|
(390 |
) |
|
|
(3,007 |
) |
|
|
(802 |
) |
|
|
(3,380 |
) |
Sales and marketing |
|
|
(895 |
) |
|
|
(731 |
) |
|
|
(1,854 |
) |
|
|
(1,277 |
)
|
General and administrative |
|
|
(689 |
) |
|
|
(605 |
) |
|
|
(1,576 |
) |
|
|
(1,229 |
) |
Operating loss |
|
|
(1,652 |
) |
|
|
(4,313 |
) |
|
|
(3,757 |
) |
|
|
(5,829 |
) |
Financial
income (expenses), net |
|
|
(64
|
) |
|
|
(27 |
) |
|
|
(147
|
) |
|
|
32 |
|
Net loss |
|
$ |
(1,716 |
) |
|
$ |
(4,340 |
) |
|
$ |
(3,904 |
) |
|
$ |
(5,797 |
) |
Six
and Three Months Ended June 30, 2022 Compared to Six and Three
Months Ended June 31, 2021
Revenues
We
started to generate revenue in 2019 and we expect to incur
additional losses to increase our sales and marketing efforts and
to perform further research and development activities. Our
revenues for the six months ended June 30, 2022 amounted to
$1,205,000 compared to $57,000 for the six months ended June 30,
2021. Our revenues for the three months ended June 30, 2022
amounted to $801,000 compared to $30,000 for the three months ended
June 30, 2021. The increase was primarily attributable to
$1,112,000 in revenue generated from Orgad from February 7, 2022,
the the date of closing of the Orgad acquisition, or the
Acquisition Date, through to the end of the second quarter 2022 and
to $752,000 in revenue generated from Orgad for the three months
ended June 30, 2022.
Cost Of Revenues
Our
cost of revenues expenses for the six and three months ended June
30, 2022 amounted to $730,000 and $479,000, respectively, compared
to none for the six and three months ended June 30, 2021. The
increase in comparison with the corresponding period was due to the
cost of goods of the revenues generated from Orgad’s
operations.
Research and Development Expenses
Our research and development expenses for the six months ended June
30, 2022 amounted to $802,000 compared to $3,380,000 for the six
months ended June 30, 2021. The decrease in comparison with the
corresponding period primarily resulted from share-based payment in
the amount of $2,618,000 that
was recorded in the corresponding period attributed to the share
issuance to Shoshana Zigdon under the Amendment to Purchase
Agreement dated May 26, 2021, and decrease in shared based expenses
to employees.
Our research and development expenses for the three months ended
June 30, 2022 amounted to $390,000 compared to $3,007,000 for the
three months ended June 30, 2021. The decrease in comparison with
the corresponding period primarily resulted from share-based
payment in amount of $2,618,000 that was recorded in the
corresponding period attributed to the share issuance to Shoshana
Zigdon under the Amendment to Purchase Agreement dated May 26, 2021
and decrease in shared based expenses to employees.
Sales and Marketing Expenses
Our sales and marketing expenses for the six months ended June 30,
2022 amounted to $1,854,000 compared to $1,277,000 for the six
months ended June 30, 2021. The increase in comparison with the
corresponding period was mainly due to the hiring of new employees
and expenses associated with Orgad activities, offset by a reduction in share-based
payment expenses to employees and consultants.
Our sales and marketing expenses for the three months ended June
30, 2022 amounted to $895,000 compared to $731,000 for the three
months ended June 30, 2021. The increase in comparison with the
corresponding period was mainly due to expenses associated with
Orgad activities, offset by a
reduction in share-based payment expenses to employees and
consultants.
General and Administrative Expenses
Our general and administrative expenses for the six months ended
June 30, 2022 amounted to $1,576,000 compared to $1,229,000 for the
six months ended June 30, 2021. The increase in comparison with the
corresponding period was mainly due to professional services
attributed to the Orgad acquisition expenses associated with Orgad
activities.
Our general and administrative expenses for the three months ended
June 30, 2022 amounted to $689,000 compared to $605,000 for the
three months ended June 30, 2021. The increase in comparison with
the corresponding period was mainly due to professional services
attributed to the Orgad expenses associated with Orgad
activities.
Operating Loss
As a
result of the foregoing, for the six months ended June 30, 2022,
our operating loss was $3,757,000 a decrease of $2,072,000 compared
to our operating loss for the six months ended June 30, 2021 of
$5,829,000.
As a
result of the foregoing, for the three months ended June 30, 2022,
our operating loss was $1,652,000 a decrease of $2,661,000 compared
to our operating loss for the three months ended June 30, 2021 of
$4,313,000.
Financial Income (Expenses), Net
Our
financial expense, net for the six months ended June 30, 2022
amounted to $147,000 compared to financial income of $32,000 for
the six months ended June 30, 2021. During the six months ended
June 30, 2022, we had financial expenses mainly from exchange rate
differences and revaluation of investment in marketable securities
whereas in the corresponding period we had financial income
primarily due revaluation of investment in marketable
securities.
Our
financial expense, net for the three months ended June 30, 2022
amounted to $64,000 compared to financial expenses of $27,000 for
the three months ended June 30, 2021. During the three months ended
June 30, 2022, we had financial expenses mainly from exchange rate
differences and revaluation of investment in marketable securities
whereas in the corresponding period we had financial expenses
primarily due revaluation of investment in marketable securities
and exchange rate differences offset in income from revaluation of
derivative.
Net Loss
As a
result of the foregoing, our net loss for the six months ended June
30, 2022 was $3,904,000, compared to net loss of $5,797,000 for the
six months ended June 30, 2021. The decrease in the net loss was
mainly due to the reasons mentioned above.
As a
result of the foregoing, our net loss for the three months ended
June 30, 2022 was $1,716,000, compared to net loss of $4,340,000
for the three months ended June 30, 2021. The decrease in the net
loss was mainly due to the reasons mentioned above.
Liquidity
and Capital Resources
Since
our inception, we have funded our operations primarily through
public and private offerings of debt and equity in the State of
Israel and in the U.S.
As of June 30, 2022, we had cash, cash equivalents, and restricted
cash of $6,725,000 compared to $10,943,000 of cash, cash
equivalents and restricted cash as of December 31, 2021. This
decrease primarily resulted from our operating activities, the
acquisition of Orgad, and resources that were deployed to grow
Orgad’s business.
Cash
used in operating activities amounted to $4,070,000 for the six
months ended June 30, 2022, compared to $2,669,000 for the six
months ended June 30, 2021. The increase in cash used in operating
activities was mainly due to the acquisition of Orgad and working
capital.
Net
cash used in investing activities was $325,000 for the six months
ended June 30, 2022, compared to cash provided by investing
activities of $172,000 for the six months ended June 30, 2021. The
increase from the corresponding period was mainly due to the
acquisition of Orgad offset by changes in restricted deposits that
occured in the six months ended June 30, 2021.
Net
cash used in financing activities was $24,000 for the six months
ended June 30, 2021, compared to cash provided by financing
activities of $5,832,000 for the six months ended June 30, 2021.
The cash flow from financing activities for the six months ended
June 30, 2021 resulted from the public offerings that occurred in
January 2021 and March 2021 and from proceeds that were received
from an investor for warrants that were exercised.
We do
not have any material commitments for capital expenditures during
the next twelve months.
We
expect that we will continue to generate losses and negative cash
flows from operations for the foreseeable future. Based on the
projected cash flows and cash balances as of June 30, 2022, we
believe our existing cash will be sufficient to fund operations for
a period less than 12 months. As a result, there is substantial
doubt about our ability to continue as a going concern. We will
need to raise additional capital, which may not be available on
reasonable terms or at all. Additional capital would be used to
accomplish the following:
|
● |
finance
our current operating expenses; |
|
|
|
|
● |
pursue
growth opportunities; |
|
|
|
|
● |
hire
and retain qualified management and key employees; |
|
|
|
|
● |
respond
to competitive pressures; |
|
|
|
|
● |
comply
with regulatory requirements; and |
|
|
|
|
● |
maintain
compliance with applicable laws. |
Current
conditions in the capital markets are such that traditional sources
of capital may not be available to us when needed or may be
available only on unfavorable terms. Our ability to raise
additional capital, if needed, will depend on conditions in the
capital markets, economic conditions, the impact of the COVID-19
pandemic, the Russian invasion of Ukraine, and a number of other
factors, many of which are outside our control, and on our
financial performance. Accordingly, we cannot assure you that we
will be able to successfully raise additional capital at all or on
terms that are acceptable to us. If we cannot raise additional
capital when needed, it may have a material adverse effect on our
business, results of operations and financial condition.
To
the extent that we raise additional capital through the sale of
equity or convertible debt securities, the issuance of such
securities could result in substantial dilution for our current
stockholders. The terms of any securities issued by us in future
capital transactions may be more favorable to new investors, and
may include preferences, superior voting rights and the issuance of
warrants or other derivative securities, which may have a further
dilutive effect on the holders of any of our securities
then-outstanding. We may issue additional shares of our common
stock or securities convertible into or exchangeable or exercisable
for our common stock in connection with hiring or retaining
personnel, option or warrant exercises, future acquisitions or
future placements of our securities for capital-raising or other
business purposes. The issuance of additional securities, whether
equity or debt, by us, or the possibility of such issuance, may
cause the market price of our common stock to decline and existing
stockholders may not agree with our financing plans or the terms of
such financings. In addition, we may incur substantial costs in
pursuing future capital financing, including investment banking
fees, legal fees, accounting fees, securities law compliance fees,
printing and distribution expenses and other costs. We may also be
required to recognize non-cash expenses in connection with certain
securities we issue, such as convertible notes and warrants, which
may adversely impact our financial condition. Furthermore, any
additional debt or equity financing that we may need may not be
available on terms favorable to us, or at all. If we are unable to
obtain such additional financing on a timely basis, we may have to
curtail our development activities and growth plans and/or be
forced to sell assets, perhaps on unfavorable terms, or we may have
to cease our operations, which would have a material adverse effect
on our business, results of operations and financial
condition.
We
have not entered into any transactions with unconsolidated entities
in which we have financial guarantees, subordinated retained
interests, derivative instruments or other contingent arrangements
that expose us to material continuing risks, contingent liabilities
or any other obligations under a variable interest in an
unconsolidated entity that provides us with financing, liquidity,
market risk or credit risk support.
Critical
Accounting Estimates
Our
management’s discussion and analysis of our financial condition and
results of operations is based on our financial statements, which
we have prepared in accordance with U.S. generally accepted
accounting principles issued by the Financial Accounting Standards
Board, or FASB. The preparation of these financial statements
requires us to make estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of
contingent assets and liabilities at the date of the financial
statements, as well as the reported expenses during the reporting
periods. Actual results may differ from these estimates under
different assumptions or conditions.
Our
significant accounting policies were revenue from contracts with
customers which are more fully described in the notes to our
financial statements appearing elsewhere in this Quarterly Report
on Form 10-Q. We believe that these accounting policies discussed
are critical to our financial results and to the understanding of
our past and future performance, as these policies relate to the
more significant areas involving management’s estimates and
assumptions. We consider an accounting estimate to be critical if:
(1) it requires us to make assumptions because information was not
available at the time or it included matters that were highly
uncertain at the time we were making our estimate; and (2) changes
in the estimate could have a material impact on our financial
condition or results of operations.
Item 3. Quantitative and Qualitative Disclosure About Market
Risk.
Not
required for a smaller reporting company.
Item 4. Controls and Procedures.
Disclosure
Controls and Procedures
We
maintain disclosure controls and procedures that are designed to
ensure that information required to be disclosed in our reports
under the Securities Exchange Act of 1934, as amended, or the
Exchange Act, and the rules and regulations thereunder, is
recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules and forms and that such
information is accumulated and communicated to our management,
including our principal executive officer and principal financial
officer, as appropriate, to allow for timely decisions regarding
required disclosure. In designing and evaluating the disclosure
controls and procedures, management recognizes that any controls
and procedures, no matter how well designed and operated, can
provide only reasonable assurance of achieving the desired control
objectives, and management is required to apply its judgment in
evaluating the cost-benefit relationship of possible controls and
procedures.
As
required by Rule 13a-15(b) under the Exchange Act, our management,
under the supervision and with the participation of our principal
executive officer and principal financial officer, has evaluated
the effectiveness of the design and operation of our disclosure
controls and procedures (as such term is defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act) as of June 30, 2022. Based
upon such evaluation, our Chief Executive Officer and Chief
Financial Officer concluded that our disclosure controls and
procedures as of June 30, 2022 were effective.
Our
Chief Executive Officer and Chief Financial Officer do not expect
that our disclosure controls and procedures or our internal
controls will prevent all error or fraud. A control system, no
matter how well conceived and operated, can provide only
reasonable, not absolute, assurance that the objectives of the
control system are met. Further, the design of a control system
must reflect the fact that there are resource constraints and the
benefits of controls must be considered relative to their costs.
Due to the inherent limitations in all control systems, no
evaluation of controls can provide absolute assurance that all
control issues and instances of fraud, if any, have been
detected.
Changes
in Internal Controls
During
the most recent fiscal quarter, no change has occurred in our
internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, our
internal control over financial reporting.
Part II – Other Information
Item 1. Legal Proceedings.
From
time to time, we may become involved in various lawsuits and legal
proceedings which arise in the ordinary course of business.
However, litigation is subject to inherent uncertainties, and an
adverse result in these or other matters may arise from time to
time that may harm our business.
North Empire LLC
On August 7, 2018, we commenced an action against North Empire LLC
(“North Empire”) in the Supreme Court of the State of New York,
County of New York for breach of a Securities Purchase Agreement
(the “Agreement”) in which we are seeking damages in an amount to
be determined at trial, but in no event less than $616,000. On
August 2, 2018, North Empire filed a Summons with Notice against
the Company, also in the same Court, in which they allege damages
in an amount of $11.4 million arising from an alleged breach of the
Agreement. On September 6, 2018 North Empire filed a Notice of
Discontinuance of the action it had filed on August 2, 2018. On
September 27, 2018, North Empire filed an answer and asserted
counterclaims in the action commenced by us against them, alleging
that we failed to deliver stock certificates to North Empire
causing damage to North Empire in the amount of $10,958,589. North
Empire also filed a third-party complaint against our CEO and now
former Chairman of the Board asserting similar claims against them
in their individual capacities. On October 17, 2018, we filed a
reply to North Empire’s counterclaims. On November 15, 2018, our
CEO and now former Chairman of the Board filed a motion to dismiss
North Empire’s third-party complaint. On January 6, 2020, the Court
granted the motion and dismissed the third-party complaint.
Discovery has been completed and both parties have filed motions
for summary judgment in connection with the claims and
counterclaims. On December 30, 2021, the Court denied both My Size
and North Empire’s motions for summary judgment, arguing there were
factual issues to be determined at trial. On January 26, 2022, we
filed a notice of appeal of the summary judgment decision. The
appeal must be fully perfected and filed by July 26, 2022. On
February 3, 2022, we filed a motion to reargue the Court’s decision
denying our motion for summary judgment. On or about March 31,
2022, North Empire filed its opposition papers to our motion to
reargue. On or about May 20, 2022, we filed our reply papers, in
further support of its motion to reargue. That motion is now fully
briefed and we are waiting on a decision from the Court.
Item 1A. Risk Factors.
Except
for the Risk Factors included in our previous filings made with the
SEC and as set forth below, there have been no material changes to
our risk factors from those disclosed in “Part I. Item 1A. Risk
Factors” in the Form 10-K filed with the SEC on March 18,
2022.
A significant majority of Orgad’s revenue is from sales of products
on Amazon’s U.S. Marketplace and any change, limitation or
restriction on our ability to operate on Amazon’s platform or any
other marketplace could have a material adverse impact to our
business, results of operations, financial condition and
prospects.
Orgad,
our wholly owned subsidiary, operates an omnichannel e-commerce
platform engaged in online retailing in the global market. It
operates as a third-party seller on Amazon.com, eBay and others. A
substantial percentage of Orgad’s revenue is driven by sales on
Amazon’s U.S. marketplace and Orgad is subject to terms of service
of Amazon and other maketplaces and various other seller policies
and services that apply to third parties selling products on Amazon
and other marketplaces. Generally, a marketplace has the right to
terminate or suspend its agreement with Orgad at any time and for
any reason. Such marketplace may take other actions against Orgad
such as suspending or terminating a seller account or product
listing and withholding payments owed to Orgad indefinitely. For
example, in July 2022, Amazon deactivated Orgad’s Amazon U.S. store
as a result of complaints submitted due to an error in the listed
manufacturer of certain products on Orgad’s store. Orgad is in the
process of having its account reinstated however if the
deactivation were to continue for a prolonged period of time, or if
Amazon were to terminate Orgad’s account, this would have a
material adverse effect on our business, results of operations,
financial condition and prospects. While Orgad endeavors to
materially comply with the terms of services of the marketplaces on
which it operates, we can provide no assurance that these
marketplaces will have the same determination with respect to our
compliance.
In
addition, Amazon and other marketplaces can make changes to its
platform that could require Orgad to change the manner in which it
operates, limit its ability to successfully launch new products or
increase its costs to operate and such changes could have an
adverse effect on our business, results of operations, financial
condition and prospects. Examples of changes that could impact us
relate to platform fee charges (i.e., selling commissions),
exclusivity, inventory warehouse availability, excluded products
and limitations on sales and marketing. Any change, limitation or
restriction on our ability to sell on Amazon’s platform or any
other marketplace, even if temporary, could have a material impact
on our business, results of operations, financial condition and
prospects.
Orgad
also relies on services provided by Amazon’s fulfillment platform,
including Prime Certification, which provides for expedited
shipping to the consumer, an important aspect in the buying
decision for consumers. For products that Orgad fulfills itself,
Orgad is qualified to offer our products for sale with Prime
Certification delivery. Any inability to market our products for
sale with expedited delivery provided under Prime Certification
could have a material impact on our business, results of
operations, financial condition and prospects. Failure to remain
compliant with the best fulfillment practices on Amazon’s platform
could have a material impact on our business, results of
operations, financial condition and prospects. In addition,
due to the COVID-19 pandemic, Amazon has changed the amount of
inventory it accepts per product for a period of time. If this were
to continue it could cause us to miss sales and/or pay additional
shipping costs which would harm our business operations and
financial conditions.
Orgad’s business depends on its ability to build and maintain
strong product listings on e-commerce platforms. Orgad may not be
able to maintain and enhance our product listings if it receives
unfavorable customer complaints, negative publicity or otherwise
fails to live up to consumers’ expectations, which could materially
adversely affect our business, results of operations and growth
prospects.
Maintaining
and enhancing Orgad’s product listings is critical in expanding and
growing its business. However, a significant portion of Orgad’s
perceived performance to the customer depends on third parties
outside of its control, including suppliers and third-party
delivery agents as well as online retailers such as Amazon and
eBay. Because Orgad’s agreements with its online retail partners
are generally terminable at will, it may be unable to maintain
these relationships, and our results of operations could fluctuate
significantly from period to period. Because Orgad relies on third
parties to deliver its products, it is subject to shipping delays
or disruptions caused by inclement weather, natural disasters,
labor activism, health epidemics or bioterrorism. It may also
experience shipping delays or disruptions due to other
carrier-related issues relating to their own internal operational
capabilities. Further, Orgad relies on the business continuity
plans of these third parties to operate during pandemics, like the
COVID-19 pandemic, and it has limited ability to influence their
plans, prevent delays, and/or cost increases due to reduced
availability and capacity and increased required safety
measures.
Customer
complaints or negative publicity about its products, delivery
times, or marketing strategies, even if not accurate, especially on
blogs, social media websites and third-party market sites, could
rapidly and severely diminish consumer view of Orgad’s product
listings and result in harm to its brand. Customers may also make
safety-related or other types of claims regarding products sold
through our online retail partners, such as Amazon, which may
result in an online retail partner removing the product from its
marketplace. We also use and rely on other services from third
parties, such as our telecommunications services, and those
services may be subject to outages and interruptions that are not
within our control.
Orgad faces risks related to successfully optimizing and operating
its fulfillment and customer service operations.
Failures
to adequately predict customer demand or otherwise optimize and
operate its fulfillment and customer service operations
successfully from time to time result in excess or insufficient
fulfillment or customer service capacity, increased costs, and
impairment charges, any of which could materially harm our
business. As Orgad continues to add fulfillment and customer
service capability or add new businesses with different
requirements, its fulfillment and customer service operations
become increasingly complex and operating them becomes more
challenging. There can be no assurance that Orgad will be able to
operate our operations effectively.
In
addition, failure to optimize inventory in our fulfillment
operations increases net shipping cost by requiring long-zone or
partial shipments. Orgad may be unable to adequately staff its
fulfillment and customer service operations. Orgad’s failure to
properly handle such inventory or to accurately forecast product
demand may result in it being unable to secure sufficient storage
space or to optimize its fulfillment operations or cause other
unexpected costs and other harm to our business and
reputation.
Orgad
relies on a limited number of shipping companies to deliver
inventory to it and completed orders to our customers. The
inability to negotiate acceptable terms with these companies or
performance problems or other difficulties experienced by these
companies could negatively impact our operating results and
customer experience. In addition, Orgad’s ability to receive
inbound inventory efficiently and ship completed orders to
customers also may be negatively affected by natural or man-made
disasters, extreme weather, geopolitical events and security
issues, labor or trade disputes, and similar
events.
The variability in Orgad’s retail business places increased strain
on its operations.
Demand
for Orgad’s product listings can fluctuate significantly for many
reasons, including as a result of seasonality, promotions, product
launches, or unforeseeable events, such as in response to natural
or man-made disasters, extreme weather, or geopolitical events. For
example, Orgad expects a disproportionate amount of our retail
sales to occur during our fourth quarter. Failure to stock or
restock popular products in sufficient amounts such that Orgad
fails to meet customer demand could significantly affect our
revenue and our future growth. If too many customers access the
websites on which Orgad engages in online retailing within a short
period of time due to increased demand, Orgad may experience system
interruptions that make the websites unavailable or prevent us from
efficiently fulfilling orders, which may reduce the volume of goods
its offers or sell and the attractiveness of its products. In
addition, Orgad may be unable to adequately staff for fulfillment
of orders and customer service during these peak periods and
delivery and other fulfillment companies and customer service
co-sourcers may be unable to meet the seasonal demand.
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not
applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934 the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
My
Size, Inc. |
|
|
|
Date:
August 15, 2022 |
By: |
/s/
Ronen Luzon |
|
|
Ronen
Luzon |
|
|
Chief
Executive Officer
(Principal
Executive Officer)
|
|
|
|
Date:
August 15, 2022 |
By: |
/s/
Or Kles |
|
|
Or
Kles |
|
|
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
|
My Size (NASDAQ:MYSZ)
Historical Stock Chart
From Apr 2023 to May 2023
My Size (NASDAQ:MYSZ)
Historical Stock Chart
From May 2022 to May 2023